Supported by National Institutes of Health Grants R01EY023285, R01EY024544, DP3 DK104397, P30 EY010572, and an unrestricted grant from Research to Prevent Blindness.
Oregon Health & Science University (OHSU), YJ, OT, and DH have a significant financial interest in Optovue, Inc., a company that may have a commercial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by Oregon Health & Science University. DH and OT receive patent royalties from Carl Zeiss Meditec, Inc. Other authors do not have financial interest in the subject of this article.
Disclosure: A.D. Pechauer, None; O. Tan, Carl Zeiss Meditec, Inc. (R), Optovue, Inc. (I); L. Liu, None; Y. Jia, Optovue, Inc. (I); V. Hou, None; W. Hills, None; D. Huang, Carl Zeiss Meditec, Inc. (R), Optovue, Inc. (I)